Group One Trading’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.51M Buy
161,236
+144,235
+848% +$1.35M ﹤0.01% 400
2025
Q1
$121K Sell
17,001
-30,241
-64% -$215K ﹤0.01% 952
2024
Q4
$551K Buy
47,242
+38,437
+437% +$448K ﹤0.01% 625
2024
Q3
$181K Buy
8,805
+174
+2% +$3.58K ﹤0.01% 727
2024
Q2
$193K Buy
+8,631
New +$193K ﹤0.01% 688
2024
Q1
Sell
-11,480
Closed -$350K 2768
2023
Q4
$350K Buy
11,480
+6,825
+147% +$208K ﹤0.01% 608
2023
Q3
$147K Sell
4,655
-4,751
-51% -$150K ﹤0.01% 818
2023
Q2
$384K Buy
+9,406
New +$384K ﹤0.01% 539
2023
Q1
Sell
-13,168
Closed -$459K 2769
2022
Q4
$459K Buy
+13,168
New +$459K ﹤0.01% 555
2022
Q3
Sell
-26,901
Closed -$1.39M 2810
2022
Q2
$1.39M Buy
+26,901
New +$1.39M ﹤0.01% 361
2022
Q1
Hold
0
2854
2021
Q4
Hold
0
2945
2021
Q3
Sell
-28,210
Closed -$4.57M 2820
2021
Q2
$4.57M Buy
28,210
+12,423
+79% +$2.01M 0.01% 250
2021
Q1
$1.27M Buy
15,787
+9,612
+156% +$771K ﹤0.01% 487
2020
Q4
$336K Buy
+6,175
New +$336K ﹤0.01% 730
2020
Q3
Hold
0
2185
2020
Q2
Sell
-11,845
Closed -$145K 1994
2020
Q1
$145K Buy
11,845
+2,391
+25% +$29.3K ﹤0.01% 606
2019
Q4
$139K Sell
9,454
-1,949
-17% -$28.7K ﹤0.01% 725
2019
Q3
$152K Buy
11,403
+10,264
+901% +$137K ﹤0.01% 653
2019
Q2
$19K Sell
1,139
-5,400
-83% -$90.1K ﹤0.01% 957
2019
Q1
$112K Buy
6,539
+800
+14% +$13.7K ﹤0.01% 613
2018
Q4
$78K Buy
5,739
+3,453
+151% +$46.9K ﹤0.01% 795
2018
Q3
$65K Sell
2,286
-9,888
-81% -$281K ﹤0.01% 910
2018
Q2
$333K Sell
12,174
-73,916
-86% -$2.02M ﹤0.01% 526
2018
Q1
$1.82M Buy
86,090
+47,223
+121% +$996K 0.02% 164
2017
Q4
$747K Buy
38,867
+31,262
+411% +$601K 0.01% 385
2017
Q3
$189K Sell
7,605
-5,767
-43% -$143K ﹤0.01% 644
2017
Q2
$214K Buy
13,372
+4,672
+54% +$74.8K ﹤0.01% 606
2017
Q1
$123K Buy
+8,700
New +$123K ﹤0.01% 659